Home › Funds › Alyeska Investment Group, L.P. › CVS
Alyeska Investment Group, L.P. position in CVS
CVS HEALTH CORP · Consumer Staples
Alyeska Investment Group, L.P. reported holding 1,685,440 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$174.4M, representing 0.45% of its reported portfolio and ranking #50 among its reported holdings. Alyeska Investment Group, L.P. has disclosed CVS holdings in 3 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Alyeska Investment Group, L.P.'s CVS position evolved
Alyeska Investment Group, L.P. first disclosed a stake in CVS in Q2 2024 at 1,014,191 shares (US$59.9M). The position peaked in Q2 2026 at 1,685,440 shares, worth US$174.4M. Across 3 filings, Alyeska Investment Group, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,685,440 shares valued at US$174.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 1.01M | $59.90M | New |
| Q4 2025 | 795.00K | $63.09M | New |
| Q2 2026 | 1.69M | $174.36M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Alyeska Investment Group, L.P.
FAQ
How long has Alyeska Investment Group, L.P. held CVS?
Alyeska Investment Group, L.P. has disclosed CVS holdings in 3 of the last 9 reported quarters, going back to Q2 2024.
What is Alyeska Investment Group, L.P.'s current position in CVS?
As of Q2 2026, Alyeska Investment Group, L.P. holds 1.69M shares of CVS (CVS HEALTH CORP), valued at $174.36M, representing 0.45% of its reported portfolio and ranking #50.
Has Alyeska Investment Group, L.P. been buying or selling CVS?
In the latest 13F filing (Q2 2026), Alyeska Investment Group, L.P. newly opened its position in CVS. The position peaked in Q2 2026 at 1.69M shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.